Latest Breaking News On - Findings presented - Page 1 : comparemela.com

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited arab emiratesUnited kingdomGreat britainColl cardiolClin cardiolMark marmurNabil abadirJournal of the american college cardiologyExchange commissionA report from the american heart associationAmarin corporationEuropean unionDrug administrationAmerican heart association

Preterm Birth Diagnostic Test Kits Market Aims for US$ 203 2 Million by 2028

Preterm Birth Diagnostic Test Kits MarketOver the next five years, the Preterm Birth Diagnostic Test Kits Market is predicted to grow at a rate of 1.6 times, with sales projected to reach US$ 121.3 million in 2021. Market growth is anticipated to occur at a compound annual growth rate (CAGR) of 7.6% between 2022 an.

New yorkUnited statesAsia pacificLiming biological preparations co ltdHologic incWuxi biohermes biomedical technology coMarket insights incAnhui deep blue medical technologyGreater new york chamberConsumer technologyClinical innovationsResearch centersPreterm birth diagnostic test kits marketBirth diagnostic test kits marketGlobal industry analysisOpportunity assessment

Researchers Identify New Cost Savings and Accuracy of C2N Diagnostics Blood Tests to Enable Healthcare Providers to Better Identify Alzheimer s Disease

Researchers Identify New Cost Savings and Accuracy of C2N Diagnostics Blood Tests to Enable Healthcare Providers to Better Identify Alzheimer s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joni hendersonSuzanne schindlerRobert rissmanMark monaneAdam shapiroJoel braunsteinChengjie xiongAlzheimer drug discovery foundationBrightfocus foundationEisai co ltd2n diagnosticsNational institute onResearch use onlyAlzheimer associationWashington university school of medicineFindings presented

VIALASE ANNOUNCES POSITIVE RESULTS OF FIRST-IN-HUMAN STUDY OF FEMTOSECOND LASER IMAGE-GUIDED HIGH-PRECISION TRABECULOTOMY (FLigHT)

/PRNewswire/ ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm.

United statesMichele grayThomasw samuelsonRichard lewisAliso viejoVialase incAmerican glaucoma societyGray communicationsPrnewswire vialase incFindings presentedGlaucoma societyMinnesota eye consultants

Preterm Birth Diagnostic Test Kits Market is anticipated to expand at a CAGR of 7 6% from 2022-2028 and will reach U S $ 203 2 Mn by 2028

Preterm Birth Diagnostic Test Kits Market is anticipated to expand at a CAGR of 7.6% from 2022-2028 and will reach U.S. $ 203.2 Mn by 2028

New yorkUnited statesUnited arab emiratesAsia pacificWuxi biohermes biomedical technology coLiming biological preparations co ltdResearch centersClinical innovationsMarket researchAnhui deep blue medical technologyGreater new york chamberHologic incFuture market insightsPreterm birth diagnostic test kits marketGlobal industry analysisOpportunity assessment